Medeon International, Inc announced a private placement of 400,040 common stock at issue price of $1 per stock for gross proceeds of $4,000,040 on June 14, 2024. The transaction will include participation from new investor, Medeon Biodesign, Inc. The transaction has been approved at the board of directors.